OceanaGold Announces Sale of the Blackwater Project for US$30M
OceanaGold Announces Sale of the Blackwater Project for US$30M
PR Newswire
VANCOUVER, BC, Jan. 31, 2024
VANCOUVER, BC, Jan. 31, 2024 /PRNewswire/ - OceanaGold Corporation (TSX: OGC) (OTCQX: OCANF) ("OceanaGold" or the "Company") is pleased to announce the execution of a Sale and Purchase Agreement ("SPA") with Tasman Mining Limited ("Tasman"), a wholly owned subsidiary of Federation Mining Inc. ("Federation"), to acquire OceanaGold's interest in the Blackwater project in New Zealand. The execution of the SPA follows the receipt of formal notice from Tasman to exercise its exclusive option on Blackwater, which has been held under a Project Deed since July 2018.
Under the terms of the SPA, OceanaGold is to receive US$30 million in cash upon closing of the transaction. The SPA is subject to a number of conditions including regulatory approval and is expected to close in 2024. For further details and background on the Blackwater option see the Company's most recent AIF (Section 11.4 Other Projects).
About OceanaGoldOceanaGold is a growing intermediate gold and copper producer committed to safely and responsibly maximizing the generation of Free Cash Flow from our operations and delivering strong returns for our shareholders. We have a portfolio of four operating mines: the Haile Gold Mine in the United States of America; Didipio Mine in the Philippines; and the Macraes and Waihi operations in New Zealand.
SOURCE OceanaGold Corporation
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Markets Brief: Stocks Are Starting to Look Cheap Again
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise
-
Microsoft Earnings: Firm Beats Forecasts on Strong AI and Cloud Demand
-
PG&E Earnings: Near-Term Regulatory Certainty Supports Industry-Leading Earnings Growth